Cy5.5 NHS Ester (Non-Sulfonated): Applied Workflows and Troubleshooting in Advanced Near-Infrared Fluorescence Imaging

Principle and Setup: Cy5.5 NHS Ester for Biomolecule Labeling and Deep-Tissue Imaging

Cy5.5 NHS ester (non-sulfonated) is a near-infrared fluorescent dye specifically engineered for covalent labeling of biomolecules with primary amino groups, such as peptides, proteins, and oligonucleotides. Featuring an excitation maximum at 684 nm and emission near 710 nm, this dye excels in in vivo fluorescence imaging and optical tumor mapping, where low background and high tissue penetration are critical. Its robust extinction coefficient (209,000 M^-1cm^-1) and quantum yield (0.2) support high-sensitivity detection, as detailed in the product information. The reactive NHS ester group ensures stable amide bond formation upon reaction with primary amines—enabling long-term signal stability and precise biomolecule tracking.

Given its low aqueous solubility, Cy5.5 NHS ester is typically dissolved in organic solvents such as DMSO (solubility ≥35.82 mg/mL) or DMF. For best results, labeling reactions are conducted in buffered aqueous solutions supplemented with a minimal percentage of organic co-solvent to ensure efficient transfer and reactivity. The dye is supplied as a solid and remains stable for up to 24 months at -20°C when protected from light, but dye solutions should be freshly prepared to preserve reactivity.

Step-by-Step Workflow: Enhancing Labeling Efficiency with Cy5.5 NHS Ester

Optimal labeling with Cy5.5 NHS ester (non-sulfonated) requires careful control of buffer conditions, solvent compatibility, and reaction timing. Here is a streamlined workflow for conjugating Cy5.5 NHS ester to proteins or polysaccharides, such as those investigated in the reference study on Oudemansiella raphanipies polysaccharides:

Protocol Parameters

• Dye dissolution: Dissolve Cy5.5 NHS ester in high-purity DMSO to a final concentration of 10 mg/mL immediately prior to use.
• Buffer conditions: Prepare target biomolecule in 0.1 M sodium bicarbonate buffer, pH 8.3, to maximize amino group reactivity and minimize hydrolysis of the NHS ester.
• Reaction setup: Add Cy5.5 NHS ester (final dye:biomolecule molar ratio 5:1) dropwise to the biomolecule solution (<5% DMSO v/v in final mix). Incubate at room temperature for 1 hour, protected from light.
• Quenching and purification: Add 10 mM Tris-HCl, pH 8.0, to quench remaining NHS ester. Purify conjugate by gel filtration or dialysis (MWCO 10-30 kDa) to remove free dye.
• Storage: Store conjugates at 4°C, protected from light, and use within 1-2 weeks for optimal fluorescence performance.

Key Innovation from the Reference Study

The reference study on Oudemansiella raphanipies polysaccharides demonstrated the power of near-infrared (NIR) fluorescence imaging for tracking the in vivo distribution of complex biomolecules. By leveraging the spectral clarity and deep-tissue penetration of NIR dyes, the researchers visualized intestinal retention of labeled polysaccharides for over 24 hours, underscoring the value of stable, covalent labeling strategies for longitudinal studies. This work highlights how polysaccharides or proteins labeled with Cy5.5 NHS ester (non-sulfonated) can be tracked in live animal models, facilitating pharmacokinetic, biodistribution, and prebiotic function assays with high spatial and temporal resolution.

Practical Translation:

• Use near-infrared dyes like Cy5.5 NHS ester for high-contrast, low-background biodistribution studies in the gastrointestinal tract or other deep tissues.
• Optimize conjugation protocols to maintain bioactivity of the labeled molecule, as demonstrated for functional polysaccharides.
• Combine NIR imaging with functional readouts (e.g., antioxidant or prebiotic assays) to correlate spatial distribution with bioactivity.

Advanced Applications: Tumor Imaging, Deep-Tissue Diagnostics, and Workflow Integration

Cy5.5 NHS ester (non-sulfonated) is widely adopted for optical imaging of tumors and deep-tissue diagnostics due to its near-infrared properties. As highlighted in recent literature, the dye’s emission at 710 nm enables imaging through several millimeters of tissue with minimal autofluorescence, making it a preferred fluorescent dye for protein conjugation in animal models. This is particularly advantageous for preclinical studies of cancer, as demonstrated by workflows targeting the tumor-microbiome axis (complementary article), where labeled antibodies or polysaccharides can delineate tumor margins, monitor intratumoral bacterial populations, or evaluate therapeutic delivery.

Moreover, Cy5.5 NHS ester facilitates multiplexing with other dyes in complex imaging panels. Its distinct spectral signature allows simultaneous tracking of multiple biomolecules, supporting systems biology approaches in cancer and immunology. The dye’s stability and covalent linkage ensure enduring signal during extended imaging sessions, as documented in studies on translational imaging and neuromodulation (extension article).

Troubleshooting and Optimization Tips for Cy5.5 NHS Ester Labeling

• Dye hydrolysis: NHS esters are sensitive to aqueous environments and alkaline pH. Prepare dye solutions fresh and minimize exposure to water before reaction. Rapid setup reduces hydrolysis and maximizes conjugation efficiency.
• Solvent compatibility: Excess DMSO or DMF can denature proteins or alter biomolecule structure. Limit organic solvent content in the reaction (<5% v/v) and validate target molecule stability prior to large-scale labeling.
• Removal of free dye: Incomplete purification can lead to high background in imaging. Employ size-exclusion chromatography or repeated dialysis to ensure removal of unconjugated Cy5.5 NHS ester.
• Signal optimization: Over-labeling may cause fluorescence quenching or functional loss. Titrate dye:biomolecule ratio and empirically determine the optimal level for your application.
• Storage precautions: Protect labeled conjugates and stock dye from light at all stages. Aliquot solid dye to avoid repeated freeze-thaw cycles.

Outlook: Frontiers in In Vivo Fluorescence Imaging with Cy5.5 NHS Ester

As the reference study and recent applied research make clear, Cy5.5 NHS ester (non-sulfonated) stands at the intersection of precision biomolecule tracking and functional in vivo analysis. Its use in tracing the fate of bioactive polysaccharides, mapping tumor boundaries, and unraveling the tumor-microbiome interface (see complement) is driving new insights in both oncology and microbiome science. The dye’s compatibility with multiplexed imaging promises even richer datasets for systems-level biology, while ongoing advances in extraction and bioconjugation techniques (such as those optimized for mushroom polysaccharides) are expanding its utility across food, pharmaceutical, and biomedical fields.

For researchers seeking a high-performance, near-infrared labeling solution, Cy5.5 NHS ester (non-sulfonated) from APExBIO offers robust spectral properties, efficient conjugation chemistry, and proven performance in demanding in vivo imaging workflows.